Skip to main content
Erschienen in: Lung 6/2019

01.11.2019 | INTERSTITIAL LUNG DISEASE

Cardiopulmonary Exercise Testing Allows Discrimination Between Idiopathic Non-specific Interstitial Pneumonia and Idiopathic Pulmonary Fibrosis in Mild to Moderate Stages of the Disease

verfasst von: Lars Hagmeyer, Simon Herkenrath, Norbert Anduleit, Marcel Treml, Winfried Randerath

Erschienen in: Lung | Ausgabe 6/2019

Einloggen, um Zugang zu erhalten

Abstract

It is unclear whether there are cardiopulmonary exercise testing (CPET) parameters which may indicate poor prognosis in the early course of fibrosing interstitial lung disease. 27 untreated consecutive subjects (13 idiopathic non-specific interstitial pneumonia (iNSIP), 14 idiopathic pulmonary fibrosis (IPF); 19 male; age 69 ± 10 years) were enrolled in this observational pilot study. Subjects underwent routine pulmonary function testing and CPET. Statistically, the t test and the Mann–Whitney-U test were applied in the presence of normal and non-normal distribution (according to Shapiro–Wilk), respectively. Analyzing the whole cohort, only mild functional impairments were determined. Comparison of iNSIP and IPF groups detected significant differences for the CPET parameters V’O2Peak[%pred] (p = 0.011), V’O2/kgPeak (p = 0.033), Watt[%pred] (p = 0.048), V’E/V’CO2 (Rest: p = 0.016; AT: p = 0.011; Peak: p = 0.019; Slope: p = 0.040), V’E/V’O2 (Rest: p = 0.033 AT: p = 0.014; Peak: p = 0.035). CPET parameters may indicate IPF-specific impairments even in mild disease. It may be hypothesized that these parameters are early biomarkers of poor prognosis.
Literatur
1.
Zurück zum Zitat Vainshelboim B, Oliveira J, Fox BD, Adir Y, Ollech JE, Kramer MR (2016) Physiological profile and limitations in exercise in idiopathic pulmonary fibrosis. J Cardiopulm Rehabil Prev 36(4):270–278CrossRef Vainshelboim B, Oliveira J, Fox BD, Adir Y, Ollech JE, Kramer MR (2016) Physiological profile and limitations in exercise in idiopathic pulmonary fibrosis. J Cardiopulm Rehabil Prev 36(4):270–278CrossRef
2.
Zurück zum Zitat Faisal A, Alghamdi BJ, Ciavaglia CE, Elbehairy AF, Webb KA, Ora J, Neder JA, O'Donnell DE (2016) Common mechanisms of dyspnea in chronic interstitial and obstructive lung disorders. Am J Respir Crit Care Med 193(3):299–309CrossRef Faisal A, Alghamdi BJ, Ciavaglia CE, Elbehairy AF, Webb KA, Ora J, Neder JA, O'Donnell DE (2016) Common mechanisms of dyspnea in chronic interstitial and obstructive lung disorders. Am J Respir Crit Care Med 193(3):299–309CrossRef
3.
Zurück zum Zitat Degani-Costa LH, Levarge B, Digumarthy SR, Eisman AS, Harris RS, Lewis GD (2015) Pulmonary vascular response patterns during exercise in interstitial lung disease. Eur Respir J 46(3):738–749CrossRef Degani-Costa LH, Levarge B, Digumarthy SR, Eisman AS, Harris RS, Lewis GD (2015) Pulmonary vascular response patterns during exercise in interstitial lung disease. Eur Respir J 46(3):738–749CrossRef
4.
Zurück zum Zitat Fell CD, Liu LX, Motika C, Kazerooni EA, Gross BH, Travis WD, Colby TV, Murray S, Toews GB, Martinez FJ, Flaherty KR (2009) The prognostic value of cardiopulmonary exercise testing in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 179(5):402–407CrossRef Fell CD, Liu LX, Motika C, Kazerooni EA, Gross BH, Travis WD, Colby TV, Murray S, Toews GB, Martinez FJ, Flaherty KR (2009) The prognostic value of cardiopulmonary exercise testing in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 179(5):402–407CrossRef
5.
Zurück zum Zitat Triantafillidou C, Manali E, Lyberopoulos P, Kolilekas L, Kagouridis K, Gyftopoulos S, Vougas K, Kotanidou A, Alchanatis M, Karakatsani A, Papiris SA (2013) The role of cardiopulmonary exercise test in IPF prognosis. Pulm Med 2013:514817CrossRef Triantafillidou C, Manali E, Lyberopoulos P, Kolilekas L, Kagouridis K, Gyftopoulos S, Vougas K, Kotanidou A, Alchanatis M, Karakatsani A, Papiris SA (2013) The role of cardiopulmonary exercise test in IPF prognosis. Pulm Med 2013:514817CrossRef
6.
Zurück zum Zitat Vainshelboim B, Oliveira J, Fox BD, Kramer MR (2016) The prognostic role of ventilatory inefficiency and exercise capacity in idiopathic pulmonary fibrosis. Respir Care 61(8):1100–1109CrossRef Vainshelboim B, Oliveira J, Fox BD, Kramer MR (2016) The prognostic role of ventilatory inefficiency and exercise capacity in idiopathic pulmonary fibrosis. Respir Care 61(8):1100–1109CrossRef
7.
Zurück zum Zitat Layton AM, Armstrong HF, Kim HP, Meza KS, D'Ovidio F, Arcasoy SM (2017) Cardiopulmonary exercise factors predict survival in patients with advanced interstitial lung disease referred for lung transplantation. Respir Med 126:59–67CrossRef Layton AM, Armstrong HF, Kim HP, Meza KS, D'Ovidio F, Arcasoy SM (2017) Cardiopulmonary exercise factors predict survival in patients with advanced interstitial lung disease referred for lung transplantation. Respir Med 126:59–67CrossRef
8.
Zurück zum Zitat Ryerson CJ, Vittinghoff E, Ley B, Lee JS, Mooney JJ, Jones KD, Elicker BM, Wolters PJ, Koth LL, King TE Jr, Collard HR (2014) Predicting survival across chronic interstitial lung disease: the ILD-GAP model. Chest 145(4):723–728CrossRef Ryerson CJ, Vittinghoff E, Ley B, Lee JS, Mooney JJ, Jones KD, Elicker BM, Wolters PJ, Koth LL, King TE Jr, Collard HR (2014) Predicting survival across chronic interstitial lung disease: the ILD-GAP model. Chest 145(4):723–728CrossRef
9.
Zurück zum Zitat Thomeer MJ, Vansteenkiste J, Verbeken EK, Demedts M (2004) Interstitial lung diseases: characteristics at diagnosis and mortality risk assessment. Respir Med 98(6):567–573CrossRef Thomeer MJ, Vansteenkiste J, Verbeken EK, Demedts M (2004) Interstitial lung diseases: characteristics at diagnosis and mortality risk assessment. Respir Med 98(6):567–573CrossRef
10.
Zurück zum Zitat Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, Colby TV, Cordier JF, Flaherty KR, Lasky JA, Lynch DA, Ryu JH, Swigris JJ, Wells AU, Ancochea J, Bouros D, Carvalho C, Costabel U, Ebina M, Hansell DM, Johkoh T, Kim DS, King TE Jr, Kondoh Y, Myers J, Muller NL, Nicholson AG, Richeldi L, Selman M, Dudden RF, Griss BS, Protzko SL, Schunemann HJ, ATS, ERS, JRS, ALAT Committee on Idiopathic Pulmonary Fibrosis, (2011) An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 183(6):788–824CrossRef Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, Colby TV, Cordier JF, Flaherty KR, Lasky JA, Lynch DA, Ryu JH, Swigris JJ, Wells AU, Ancochea J, Bouros D, Carvalho C, Costabel U, Ebina M, Hansell DM, Johkoh T, Kim DS, King TE Jr, Kondoh Y, Myers J, Muller NL, Nicholson AG, Richeldi L, Selman M, Dudden RF, Griss BS, Protzko SL, Schunemann HJ, ATS, ERS, JRS, ALAT Committee on Idiopathic Pulmonary Fibrosis, (2011) An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 183(6):788–824CrossRef
11.
Zurück zum Zitat Travis WD, Costabel U, Hansell DM, King TE Jr, Lynch DA, Nicholson AG, Ryerson CJ, Ryu JH, Selman M, Wells AU, Behr J, Bouros D, Brown KK, Colby TV, Collard HR, Cordeiro CR, Cottin V, Crestani B, Drent M, Dudden RF, Egan J, Flaherty K, Hogaboam C, Inoue Y, Johkoh T, Kim DS, Kitaichi M, Loyd J, Martinez FJ, Myers J, Protzko S, Raghu G, Richeldi L, Sverzellati N, Swigris J, Valeyre D, ATS, ERS Committee on Idiopathic Interstitial Pneumonias, (2013) An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 188(6):733–748CrossRef Travis WD, Costabel U, Hansell DM, King TE Jr, Lynch DA, Nicholson AG, Ryerson CJ, Ryu JH, Selman M, Wells AU, Behr J, Bouros D, Brown KK, Colby TV, Collard HR, Cordeiro CR, Cottin V, Crestani B, Drent M, Dudden RF, Egan J, Flaherty K, Hogaboam C, Inoue Y, Johkoh T, Kim DS, Kitaichi M, Loyd J, Martinez FJ, Myers J, Protzko S, Raghu G, Richeldi L, Sverzellati N, Swigris J, Valeyre D, ATS, ERS Committee on Idiopathic Interstitial Pneumonias, (2013) An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 188(6):733–748CrossRef
12.
Zurück zum Zitat American Thoracic Society, American College of Chest Physicians (2003) ATS/ACCP statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med:167(2):211.CrossRef American Thoracic Society, American College of Chest Physicians (2003) ATS/ACCP statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med:167(2):211.CrossRef
13.
Zurück zum Zitat Task Force ERS, Palange P, Ward SA, Carlsen KH, Casaburi R, Gallagher CG, Gosselink R, O'Donnell DE, Puente-Maestu L, Schols AM, Singh S, Whipp BJ (2007) Recommendations on the use of exercise testing in clinical practice. Eur Respir J 29(1):185–209 Task Force ERS, Palange P, Ward SA, Carlsen KH, Casaburi R, Gallagher CG, Gosselink R, O'Donnell DE, Puente-Maestu L, Schols AM, Singh S, Whipp BJ (2007) Recommendations on the use of exercise testing in clinical practice. Eur Respir J 29(1):185–209
14.
Zurück zum Zitat Baba R, Nagashima M, Goto M, Nagano Y, Yokota M, Tauchi N, Nishibata K (1996) Oxygen uptake efficiency slope: a new index of cardiorespiratory functional reserve derived from the relation between oxygen uptake and minute ventilation during incremental exercise. J Am Coll Cardiol 28(6):1567–1572CrossRef Baba R, Nagashima M, Goto M, Nagano Y, Yokota M, Tauchi N, Nishibata K (1996) Oxygen uptake efficiency slope: a new index of cardiorespiratory functional reserve derived from the relation between oxygen uptake and minute ventilation during incremental exercise. J Am Coll Cardiol 28(6):1567–1572CrossRef
15.
Zurück zum Zitat Agusti AG, Roca J, Gea J, Wagner PD, Xaubet A, Rodriguez-Roisin R (1991) Mechanisms of gas-exchange impairment in idiopathic pulmonary fibrosis. Am Rev Respir Dis 143(2):219–225CrossRef Agusti AG, Roca J, Gea J, Wagner PD, Xaubet A, Rodriguez-Roisin R (1991) Mechanisms of gas-exchange impairment in idiopathic pulmonary fibrosis. Am Rev Respir Dis 143(2):219–225CrossRef
16.
Zurück zum Zitat Wallaert B, Guetta A, Wemeau-Stervinou L, Terce G, Valette M, Neviere R, Aguilaniu B (2011) Prognostic value of clinical exercise testing in idiopathic pulmonary fibrosis. Rev Mal Respir 28(3):290–296CrossRef Wallaert B, Guetta A, Wemeau-Stervinou L, Terce G, Valette M, Neviere R, Aguilaniu B (2011) Prognostic value of clinical exercise testing in idiopathic pulmonary fibrosis. Rev Mal Respir 28(3):290–296CrossRef
17.
Zurück zum Zitat Miki K, Maekura R, Hiraga T, Okuda Y, Okamoto T, Hirotani A, Ogura T (2003) Impairments and prognostic factors for survival in patients with idiopathic pulmonary fibrosis. Respir Med 97(5):482–490CrossRef Miki K, Maekura R, Hiraga T, Okuda Y, Okamoto T, Hirotani A, Ogura T (2003) Impairments and prognostic factors for survival in patients with idiopathic pulmonary fibrosis. Respir Med 97(5):482–490CrossRef
18.
Zurück zum Zitat Nathan SD, Meyer KC (2014) IPF clinical trial design and endpoints. Curr Opin Pulm Med 20(5):463–471CrossRef Nathan SD, Meyer KC (2014) IPF clinical trial design and endpoints. Curr Opin Pulm Med 20(5):463–471CrossRef
19.
Zurück zum Zitat King TE Jr, Tooze JA, Schwarz MI, Brown KR, Cherniack RM (2001) Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model. Am J Respir Crit Care Med 164(7):1171–1181CrossRef King TE Jr, Tooze JA, Schwarz MI, Brown KR, Cherniack RM (2001) Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model. Am J Respir Crit Care Med 164(7):1171–1181CrossRef
20.
Zurück zum Zitat Erbes R, Schaberg T, Loddenkemper R (1997) Lung function tests in patients with idiopathic pulmonary fibrosis. Are they helpful for predicting outcome? Chest 111(1), 51–57.CrossRef Erbes R, Schaberg T, Loddenkemper R (1997) Lung function tests in patients with idiopathic pulmonary fibrosis. Are they helpful for predicting outcome? Chest 111(1), 51–57.CrossRef
Metadaten
Titel
Cardiopulmonary Exercise Testing Allows Discrimination Between Idiopathic Non-specific Interstitial Pneumonia and Idiopathic Pulmonary Fibrosis in Mild to Moderate Stages of the Disease
verfasst von
Lars Hagmeyer
Simon Herkenrath
Norbert Anduleit
Marcel Treml
Winfried Randerath
Publikationsdatum
01.11.2019
Verlag
Springer US
Erschienen in
Lung / Ausgabe 6/2019
Print ISSN: 0341-2040
Elektronische ISSN: 1432-1750
DOI
https://doi.org/10.1007/s00408-019-00282-9

Weitere Artikel der Ausgabe 6/2019

Lung 6/2019 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.